DAN A22 (Ranitidine Hydrochloride 150 mg)
Pill with imprint DAN A22 is Yellow, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Schein.
Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; duodenal ulcer prophylaxis; gerd; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DAN A22
Ranitidine Hydrochloride
- Imprint
- DAN A22
- Strength
- 150 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Schein
- National Drug Code (NDC)
- 00364-2633
More about ranitidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- En Español
- 153 Reviews
- Drug class: H2 antagonists
- FDA Alerts (18)
Consumer resources
- Patient Information
- Ranitidine Injection
- Ranitidine Suspension
- Ranitidine Syrup
- Ranitidine Tablets and Capsules
- Other brands
- Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.